Table 3.
Treatment group analysis.
Treatment group analysis | CIMT‡ | Robotic Therapy‡ | p-value |
---|---|---|---|
WMFT median time, seconds | −24.36 (−133.80−5.08) | −11.09 (−27.56−8.87) | 0.293 |
FMA—UL | 4.5 (1.5−7) | 2.7 (−2−6) | 0.187 |
WMFT (Ability) | 0.27 (0.1−0.7) | 0.30 (0.27−0.6) | 0.769 |
AMAT (Ability) | 0.27 (0.19−0.91) | 0.41 (0.17−0.79) | 0.988 |
AMAT (Quality) | 0.50 (0.22−0.79) | 0.53 (0.17−0.89) | 0.792 |
MAS | −0.05 (−0.66−0) | 0 (−0.11−0.05) | 0.014 |
FIM | 1.5 (0−5.25) | 3.0 (2.0−5.75) | 0.517 |
SIS (total score) | 6.77 (0−15.20) | 7.04 (1.89−11.64) | 0.761 |
SIS strength | 0 (−12.5−18.75) | 15.63 (−6.25−25) | 0.122 |
SIS Activities of Daily Living | 10 (0−15) | 10.0 (−2.5−17.5) | 0.855 |
SIS Hand Function | 15.0 (5−25) | 17.5 (5.0−25) | 0.939 |
CMIT, constraint-induced movement therapy; WMFT, wolf motor function test (mean time in seconds); FMA—UL, upper limb fugl meyer assessment; AMAT, arm motor ability test; MAS, modified ashworth scale; FIM, functional independence measure; SIS, stroke impact scale;
Median change from baseline.